Wellington Management
http://www.wellington.comWellington Management is an independent investment management company. The firm invests in a broad range of asset classes including global equity, fixed income, currency and commodity markets, including multi-strategy, specialty and alternative investment approaches.
View Older Stories View More Recent Stories
-
Form SCHEDULE 13G/A ARGAN INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G IDACORP INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A HELIOS TECHNOLOGIES, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A REDWOOD TRUST INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A ESSENTIAL PROPERTIES Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A FLUOR CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A MYRIAD GENETICS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A AZEK Co Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A RYDER SYSTEM INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A EQT Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A AMICUS THERAPEUTICS, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Chefs' Warehouse, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G DXP ENTERPRISES INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G PATRICK INDUSTRIES INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A WEX Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Wall Street 2.0: Ondo Finance Unveils Integrated Infrastructure Suite to Bring US Financial Markets onto the Blockchain
-
Form SCHEDULE 13G QIAGEN N.V. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A Coterra Energy Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Analysis-Investors on guard as US tariff threats evolve
-
M Science Further Strengthens Management Team
-
Helicore Biopharma Emerges from Stealth to Continue Advancing Portfolio of First-in-Class GIP Antagonists for Obesity and Related Conditions
-
XA Investments Non-Listed Closed End Funds Fourth Quarter 2024 Market Update Shows Record Growth
-
Abnormal Security Appoints Lisa Banks as Chief Financial Officer
-
BetterUp Launches AI Coaching: Bridging Human Expertise and AI Innovation to Transform Organizational Impact at Scale
-
ROYC Appoints Advisory Board to Drive Strategic Growth and Innovation
-
Dataiku Surpasses $300M ARR Milestone, Accelerating GenAI Adoption and ROAI in Global Enterprises
-
Shonda Rhimes, Brené Brown, Adam Grant and Dr. Becky Kennedy Headline BetterUp’s Uplift 2025
-
Genius Sports (GENI) Announces Pricing of Public Offering
-
Genius Sports Announces Pricing of Public Offering
-
Saluda Medical Announces Closing of $100 Million Financing
-
US companies rush to bond market in fundraising flurry
-
Wellington Management Launches First Interval Fund and Expands Investment Offerings For U.S. Wealth Investors
-
FalconX Expands Global Derivatives Footprint with Acquisition of Arbelos Markets
-
JOHN HANCOCK HEDGED EQUITY & INCOME FUND - REQUIRED NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)
-
GrowthCap Announces GrowthCap's Top 40 Under 40 Growth Investors of 2024
-
SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-opioid Treatments for Pain
-
AI startup Databricks hits $62 billion valuation in record VC round
-
Databricks is Raising $10B Series J Investment at $62B Valuation
-
Current Announces Record-Breaking Growth in 2024; Secures Additional Capital to Accelerate Scale, Product Innovation
-
Archer Aviation raises $430 million through equity offering, partners with Anduril
-
Archer Aviation (ACHR) Announces Strategic Partnership With Anduril to Develop Hybrid VTOL Military Aircraft; Raises An Additional $430M
-
Archer Announces Strategic Partnership With Anduril to Develop Hybrid VTOL Military Aircraft; Raises An Additional $430M
-
Nevatia Joins Fiduciary Trust Company as Chief Operating Officer
-
Chroma Medicine and Nvelop Therapeutics Unite to Form nChroma Bio, Securing $75 Million to Accelerate Genetic Medicines
-
BetterUp Expands Partnership with Workday to Help Managers Act on Employee Feedback and Drive Measurable Results
-
AMP Raises $91 Million in Series D Funding to Revolutionize Waste
-
Form SCHEDULE 13G/A Option Care Health, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Olema Pharmaceuticals (OLMA) Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement
-
Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement
-
Nasdaq Private Market Announces 2024 Executive Leadership Team Promotions

